Create a Bitpanda account and confirm your email address.
Confirm your identity with one of our trusted verification partners and deposit funds.
You’re all set! Start investing with Bitpanda Stocks in Argenx and over 2,500 other digital assets.
argenx SE is a clinical-stage biotechnology company which engages in the development of antibody-based therapies for the treatment of autoimmune diseases and cancer. Its products include for example ARGX-117 and ARGX-119. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Breda, the Netherlands.